CreoSG Co.,Ltd. (KOSDAQ:040350)
904.00
+1.00 (0.11%)
At close: Feb 27, 2026
CreoSG Revenue
CreoSG had revenue of 2.89B KRW in the quarter ending September 30, 2025, with 36.34% growth. This brings the company's revenue in the last twelve months to 9.69B, up 19.74% year-over-year. In the year 2024, CreoSG had annual revenue of 8.16B, down -16.39%.
Revenue (ttm)
9.69B
Revenue Growth
+19.74%
P/S Ratio
9.08
Revenue / Employee
230.79M
Employees
42
Market Cap
88.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.16B | -1.60B | -16.39% |
| Dec 31, 2023 | 9.76B | -24.95M | -0.26% |
| Dec 31, 2022 | 9.78B | 1.15B | 13.27% |
| Dec 31, 2021 | 8.64B | -1.18B | -12.02% |
| Dec 31, 2020 | 9.82B | -131.70M | -1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Home Center Holdings Co.,Ltd | 305.10B |
| ICD Co., Ltd. | 207.33B |
| WiTS Co., Ltd. | 143.66B |
| Sinsin Pharmaceutical | 110.29B |
| Enzychem Lifesciences | 72.17B |
| Polaris AI Pharma | 63.94B |
| RF Systems | 36.01B |
| Enertork | 23.47B |